MBND holdings: all 69 positions
MBND held 69 positions as of Oct 13, 2026. Azshgr 5.000 07/01/34 is the largest at 2.95%; the top 10 are 25.8% of the fund.
Every position
| # | Holding | Weight ↓ |
|---|---|---|
| 1 | Azshgr 5.000 07/01/34 | 2.95% |
| 2 | Utsgen 4.375 06/01/40 | 2.82% |
| 3 | Nmsmed 4.000 08/01/39 | 2.73% |
| 4 | Nycdev 3.000 03/01/36 | 2.64% |
| 5 | Sfotrn 5.000 08/01/34 | 2.57% |
| 6 | Seepwr 5.000 11/01/35 | 2.51% |
| 7 | Trbgen 5.000 12/01/34 | 2.44% |
| 8 | Maiutl 5.000 12/01/53 | 2.40% |
| 9 | Nysdev 5.000 11/15/41 | 2.37% |
| 10 | Ccedev 5.000 09/01/32 | 2.36% |
| 11 | Forscd 4.000 02/15/33 | 2.36% |
| 12 | Melpwr 5.000 01/01/48 | 2.23% |
| 13 | Okstrn 5.000 01/01/44 | 2.16% |
| 14 | Ohsmed 3.250 01/01/35 | 2.09% |
| 15 | Mishgr 5.000 02/15/30 | 2.03% |
| 16 | Njstrn 5.000 01/01/29 | 2.02% |
| 17 | Trcfac 5.000 12/01/39 | 1.99% |
| 18 | Ccedev 5.000 02/01/54 | 1.98% |
| 19 | Unihgr 5.000 08/15/27 | 1.97% |
| 20 | Arsdev 5.450 09/01/52 | 1.93% |
| 21 | Txstrn 5.500 12/31/58 | 1.89% |
| 22 | Oksedu 4.000 09/01/38 | 1.76% |
| 23 | Miautl 3.000 10/01/36 | 1.74% |
| 24 | Kysdev 4.250 07/01/35 | 1.70% |
| 25 | Trbgen 5.000 12/01/33 | 1.53% |
| 26 | Nhpfac 5.500 01/01/57 | 1.52% |
| 27 | Duldev 4.000 06/15/37 | 1.42% |
| 28 | Wismed 3.000 10/15/37 | 1.40% |
| 29 | Sfogen 5.750 09/01/53 | 1.34% |
| 30 | Ilwdev 5.250 07/01/48 | 1.33% |
| 31 | Ricmed 3.000 01/01/33 | 1.25% |
| 32 | Norhgr 4.000 04/01/37 | 1.22% |
| 33 | Oksmed 5.000 08/15/38 | 1.17% |
| 34 | Flsdev 4.500 07/01/32 | 1.14% |
| 35 | Cenpwr 5.000 05/01/54 | 1.11% |
| 36 | Lasfac 4.000 04/01/39 | 1.11% |
| 37 | Metapt 4.000 10/01/38 | 1.09% |
| 38 | OLA 3.000 10/01/31 | 1.09% |
| 39 | Psbdev 4.000 11/01/39 | 1.05% |
| 40 | Nyttrn 6.000 04/01/35 | 1.03% |
| 41 | CAS 5.000 03/01/30 | 1.02% |
| 42 | SAN 5.000 02/01/30 | 1.02% |
| 43 | Utspwr 5.000 09/01/32 | 1.02% |
| 44 | Chitrn 5.000 01/01/38 | 1.00% |
| 45 | Orafac 5.000 08/15/37 | 0.99% |
| 46 | Lastrn 4.150 09/01/27 | 0.97% |
| 47 | Flsdev 12.000 07/01/57 | 0.96% |
| 48 | Vayscd 5.000 02/15/29 | 0.96% |
| 49 | Flsdev 4.375 10/01/54 | 0.95% |
| 50 | Mdstrn 5.000 08/01/30 | 0.81% |
| 51 | Iasgen 4.000 12/01/50 | 0.79% |
| 52 | Jefutl 5.250 10/01/40 | 0.78% |
| 53 | Txspwr 3.000 09/01/39 | 0.78% |
| 54 | Wasmed 5.000 08/15/37 | 0.78% |
| 55 | Pubedu 6.000 06/15/52 | 0.74% |
| 56 | Cosmed 4.000 08/01/37 | 0.73% |
| 57 | Sfoapt 5.000 05/01/28 | 0.70% |
| 58 | ILS 5.000 12/01/31 | 0.59% |
| 59 | Cashsg 3.500 11/20/35 | 0.54% |
| 60 | Ceadev 5.500 05/01/44 | 0.51% |
| 61 | Vasdev 5.000 06/30/39 | 0.49% |
| 62 | Misfin 5.000 11/01/34 | 0.44% |
| 63 | Stlapt 5.000 07/01/29 | 0.41% |
| 64 | Lewscd 5.000 08/15/28 | 0.40% |
| 65 | ILS 3.250 11/01/26 | 0.39% |
| 66 | Pasdev 5.250 12/01/37 | 0.39% |
| 67 | Spvgen 6.250 09/01/53 | 0.38% |
| 68 | Pmrmed 0.000 08/01/27 | 0.37% |
| 69 | Mardev 4.000 10/15/47 | 0.31% |
| US Dollar | 6.39% | |
| Cash and other net assets | −0.05% |
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of MBND, data as of Oct 13, 2026. https://etfiq.com/funds/mbnd/holdings/
ETFIQ. (Oct 13, 2026). Holdings of MBND. Retrieved from https://etfiq.com/funds/mbnd/holdings/
[Holdings of MBND (ETFIQ, Oct 13, 2026)](https://etfiq.com/funds/mbnd/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.